CIAS
CBIZ Investment Advisory Services Portfolio holdings
AUM
$2.26B
1-Year Return
12.28%
This Quarter Return
+8.47%
1 Year Return
+12.28%
3 Year Return
+37%
5 Year Return
+55.03%
10 Year Return
–
AUM
$2.26B
AUM Growth
+$216M
(+11%)
Cap. Flow
+$53M
Cap. Flow
% of AUM
2.35%
Top 10 Holdings %
Top 10 Hldgs %
94.67%
Holding
767
New
147
Increased
329
Reduced
136
Closed
26
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
$18.5M |
| 2 |
Vanguard Growth ETF
VUG
|
$15.6M |
| 3 |
Vanguard Value ETF
VTV
|
$9.49M |
| 4 |
Invesco QQQ Trust
QQQ
|
$6.81M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$6.11M |
Top Sells
Sector Composition
| 1 | Industrials | 2.06% |
| 2 | Technology | 0.37% |
| 3 | Financials | 0.16% |
| 4 | Healthcare | 0.09% |
| 5 | Consumer Discretionary | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Fiserv
FI
$73.7B
| $14.7K | ﹤0.01% |
85
+56
| +193% | +$9.66K |
|
302
Honda
HMC
$44.4B
| $14.4K | ﹤0.01% |
500
| – | – |
|
303
Fortinet
FTNT
$58.3B
| $14.4K | ﹤0.01% |
136
+56
| +70% | +$5.92K |
|
304
iShares Biotechnology ETF
IBB
$5.65B
| $14.3K | ﹤0.01% |
113
| – | – |
|
305
D.R. Horton
DHI
$52.6B
| $14.2K | ﹤0.01% |
110
-25
| -19% | -$3.24K |
|
306
Blackstone
BX
$132B
| $13.8K | ﹤0.01% |
92
-60
| -39% | -$8.98K |
|
307
Amgen
AMGN
$151B
| $13.7K | ﹤0.01% |
49
-43
| -47% | -$12K |
|
308
Eversource Energy
ES
$23.4B
| $13.6K | ﹤0.01% |
214
+203
| +1,845% | +$12.9K |
|
309
Kforce
KFRC
$584M
| $13.6K | ﹤0.01% |
329
+1
| +0.3% | +$41 |
|
310
Zscaler
ZS
$41.6B
| $13.5K | ﹤0.01% |
43
+11
| +34% | +$3.45K |
|
311
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$8.94B
| $13.3K | ﹤0.01% |
378
| – | – |
|
312
Citizens Financial Group
CFG
$22.4B
| $13.3K | ﹤0.01% |
298
-177
| -37% | -$7.92K |
|
313
iShares Core Dividend Growth ETF
DGRO
$33.6B
| $13.2K | ﹤0.01% |
206
| – | – |
|
314
Sony
SONY
$166B
| $13K | ﹤0.01% |
500
| – | – |
|
315
Zoetis
ZTS
$67.5B
| $12.9K | ﹤0.01% |
83
+61
| +277% | +$9.51K |
|
316
Esquire Financial Holdings
ESQ
$818M
| $12.6K | ﹤0.01% |
+133
| New | +$12.6K |
|
317
Gilead Sciences
GILD
$140B
| $12.6K | ﹤0.01% |
114
-20
| -15% | -$2.21K |
|
318
Neurocrine Biosciences
NBIX
$13.7B
| $12.6K | ﹤0.01% |
100
| – | – |
|
319
Halliburton
HAL
$19.1B
| $12.3K | ﹤0.01% |
602
-174
| -22% | -$3.55K |
|
320
LyondellBasell Industries
LYB
$17.5B
| $12.2K | ﹤0.01% |
210
+162
| +338% | +$9.37K |
|
321
CRH
CRH
$74.6B
| $12.1K | ﹤0.01% |
132
+49
| +59% | +$4.5K |
|
322
Williams Companies
WMB
$70.3B
| $12.1K | ﹤0.01% |
192
-47
| -20% | -$2.95K |
|
323
Nike
NKE
$111B
| $12K | ﹤0.01% |
169
+41
| +32% | +$2.92K |
|
324
Invesco S&P 500 Revenue ETF
RWL
$6.28B
| $12K | ﹤0.01% |
115
| – | – |
|
325
Regions Financial
RF
$24.2B
| $12K | ﹤0.01% |
503
+395
| +366% | +$9.39K |
|